Royalty Pharma plc (RPRX)

Royalty Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	929.03	477.01	1,711	1,541	1,009
Short-Term Investments	58.2	18.3	25.72	647.87	1,053
Cash & Short-Term Investments	987.23	495.31	1,736	2,189	2,062
Cash Growth	99.31%	-71.48%	-20.67%	6.16%	505.29%
Accounts Receivable	810.73	760.84	727.92	682.66	626.36
Receivables	810.73	760.84	727.92	682.66	626.36
Other Current Assets	4.19	18.04	90.52	6.63	8.6
Total Current Assets	1,802	1,274	2,555	2,878	2,697
Long-Term Investments	1,260	1,012	735.82	909.59	916.64
Other Intangible Assets	5.32	1.78	14.5	5.67	28.67
Long-Term Accounts Receivable	15,127	14,089	13,493	13,718	12,368
Other Long-Term Assets	28.21	4.74	15.13	4.14	10
Total Assets	18,223	16,382	16,813	17,516	16,020
Accounts Payable	13.37	15.17	7.91	5.62	10.78
Accrued Expenses	98.06	51.68	54.16	57.7	60.75
Current Portion of Long-Term Debt	997.77	-	997.51	-	-
Other Current Liabilities	144.41	94.53	107.2	107.93	236.37
Total Current Liabilities	1,254	161.38	1,167	171.25	307.89
Long-Term Debt	6,615	6,135	6,119	7,096	5,817
Other Long-Term Liabilities	12.08	0.9	2.5	-	-
Total Liabilities	7,880	6,298	7,288	7,267	6,124
Common Stock	0.11	0.11	0.11	0.11	0.1
Additional Paid-In Capital	4,103	4,011	3,666	3,508	2,866
Retained Earnings	2,846	2,518	1,965	2,255	1,921
Treasury Stock	-2.66	-2.63	-2.81	-2.72	-2.32
Comprehensive Income & Other	-	-	-	16.49	34.4
Total Common Equity	6,947	6,526	5,628	5,777	4,819
Minority Interest	3,396	3,558	3,897	4,472	5,077
Shareholders' Equity	10,342	10,084	9,525	10,249	9,896
Total Liabilities & Equity	18,223	16,382	16,813	17,516	16,020
Total Debt	7,612	6,135	7,116	7,096	5,817
Net Cash (Debt)	-6,625	-5,640	-5,380	-4,907	-3,755
Net Cash Per Share	-11.15	-9.35	-12.28	-11.83	-10.00
Filing Date Shares Outstanding	433.32	446.69	443.17	432.96	388.13
Total Common Shares Outstanding	445.99	446.69	443.17	432.96	388.14
Working Capital	548.52	1,113	1,388	2,707	2,389
Book Value Per Share	15.58	14.61	12.70	13.34	12.42
Tangible Book Value	6,941	6,525	5,614	5,771	4,790
Tangible Book Value Per Share	15.56	14.61	12.67	13.33	12.34

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q